How reliable are reported plasma clozapine levels?

References

• Ackenheil V, Bräu H, Burkhart A, Franke A, Pacha W. Antipsychotische wirksamkeit im verhälnis zum plasmaspiegel von clozapin [Antipsychotic efficacy in relation to plasma levels of clozapine]. Arzneimittelforschung 1976; 26: 1156–1158
   PubMed Web of Science ®Google Scholar
• Potkin S G, Bera R, Gulasekaram B, et al. Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia. Journal of Clinical Psychiatry 1994; 55(Suppl. B)133–136
   PubMed Web of Science ®Google Scholar
• Haring C, Fleischhacker W W, Schett P, et al. Influence of patient-related variables on clozapine plasma levels. American Journal of Psychiatry 1990; 147: 1471–1475
   PubMed Web of Science ®Google Scholar
• Oyewumi L K, Freeman D J, Vollick D. Can low-dose clozapine pharmacokinetics predict steady-state plasma concentration?. Therapeutic Drug Monitoring 1995; 17: 137–141
   PubMed Web of Science ®Google Scholar
• Hasegawa M, Gutierrez-Esteinou R, Way L, Meltzer H Y. Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: effect of smoking. Journal of Clinical Psychopharmacology 1993; 13: 383–390
   PubMed Web of Science ®Google Scholar
• Haring C, Meise U, Humpel C, et al. Dose-related plasma levels of clozapine: influence of smoking behaviour, sex and age. Psychopharmacology 1989; 99: S38–S40
   PubMed Web of Science ®Google Scholar
• Bell R, McLaren A, Galanos J, Copolov D. The clinical use of plasma clozapine levels. Australian and New Zealand Journal of Psychiatry 1998; 32: 567–574
   PubMed Web of Science ®Google Scholar
• Miller D D, Fleming F, Holman T L, Perry P J. Plasma clozapine concentrations as a predictor of clinical response: a follow-up study. Journal of Clinical Psychiatry 1994; 55(Suppl. B)117–121
   PubMed Web of Science ®Google Scholar
• Kronig M H, Munne R A, Szymanski S, et al. Plasma clozapine levels and clinical response for treatment-refractory schizophrenic patients. American Journal of Psychiatry 1995; 152: 179–182
   PubMed Web of Science ®Google Scholar
• Copolov D, Bell W R, Benson W, Keks N, Johnson G. Clozapine treatment in Australia –a review of haematological monitoring. Medical Journal of Australia 1998; 168: 495–497
   PubMed Web of Science ®Google Scholar
• Alvir J, Ma J, Lieberman A J, et al. Clozapine-induced agranulocytosis: incidence and risk factors in the United States. New England Journal of Medicine 1993; 329: 162–167
   PubMed Web of Science ®Google Scholar
• Naber D, Holzbach R, Perro C, Hippius H. Clinical management of clozapine patients in relation to efficacy and side-effects. British Journal of Psychiatry 1992; 160: 54–59
   Web of Science ®Google Scholar
• Pirmohamed M, Williams D, Madden S, Templeton E, Park B K. Metabolism and bioactivation of clozapine by human liver in vitro. Journal of Pharmacology and Experimental Therapeutics 1995; 272: 984–990
   PubMed Web of Science ®Google Scholar
• Chung M-C, Lin S-K, Chang W-H. Determination of clozapine and desmethylclozapine in human plasma by high-performance liquid chromatography with ultraviolet detection. Journal of Chromatography 1993; 613: 168–173
   PubMed Web of Science ®Google Scholar
• Gelenberg A J. Clozapine-induced agranulocytosis and seizures. Biology of Therapeutic Psychiatry 1989; 12: 2–3
   Google Scholar
• Lieberman J A, Safferman A Z. Clinical profile of clozapine: adverse reactions and agranulocytosis. Psychiatric Quarterly 1992; 63: 51–70
   PubMedGoogle Scholar
• Lovdahl M J, Perry P J, Miller D D. The assay of clozapine and N-desmethylclozapine in human plasma by high-performance liquid chromatography. Therapeutic Drug Monitoring 1991; 13: 69–72
   PubMed Web of Science ®Google Scholar
• Centorrino F, Baldessarini R J, Kando J, et al. Plasma concentrations of clozapine and its major metabolites: effects of co-treatment with fluoxetine or valproate. American Journal of Psychiatry 1994; 151: 123–125
   PubMed Web of Science ®Google Scholar
• Bondesson V, Lindstrom L H. Determination of clozapine and its N-demethylated metabolite in plasma by use of gas chromatography-mass spectrometry with single ion detection. Psychopharmacology 1988; 95: 471–475
   Web of Science ®Google Scholar
• Lieberman J A, Kane J M, Safferman A Z, et al. Predictors of response to clozapine. Journal of Clinical Psychiatry 1994; 55: 126–128
   PubMed Web of Science ®Google Scholar
• Marascuilo L A, McSweeney M. Nonparametric and distribution-free methods for the social sciences. Brooks/Cole, Monterey, CA 1977; 58–61
   Google Scholar
• Akerman K K. Analysis of clozapine and norclozapine by high-performance liquid chromatography. Journal of Chromatography and B: Biomedical and Scientific Applications 1997; 696: 253–259
   PubMed Web of Science ®Google Scholar